表紙
市場調查報告書

羊膜的全球市場:2020年∼2024年

Amniotic Membrane Market by Type and Geography - Forecast and Analysis 2020-2024

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 920959
出版日期 內容資訊 英文 145 Pages
訂單完成後即時交付
價格
Back to Top
羊膜的全球市場:2020年∼2024年 Amniotic Membrane Market by Type and Geography - Forecast and Analysis 2020-2024
出版日期: 2019年12月16日內容資訊: 英文 145 Pages
簡介

全球羊膜市場上,眼科手術的羊膜移植廣泛的利用,傷的修復和重組中羊膜的高需求,生物相容性支架的需求增加等成為成長促進因素,在預測期間內預計將以13%以上的年複合成長率擴大。但,有限的羊膜供給,嚴格法規的存在,保存及污染相關問題等要素,可能妨礙在預測期間內羊膜市場成長。

本報告提供全球羊膜市場相關調查分析,市場規模及成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,再加上主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

  • 簡介1
  • 簡介2
  • 美金的貨幣換算比率

第3章 市場情形

  • 市場生態系統
  • 市場特徵
  • 市場區隔分析

第4章 市場規模

  • 市場定義
  • 市場規模(2019年)
  • 市場規模及預測(2019年∼2024年)
  • 市場預測

第5章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情況

第6章 市場區隔:各類型

  • 市場區隔:各類型
  • 各類型比較:市場規模及預測(2019年∼2024年)
  • 凍結保存羊膜
  • 乾燥羊膜
  • 市場機會:各類型

第7章 客戶形勢

第8章 各地區形勢

  • 各地區市場區隔
  • 各地區比較:市場規模及預測(2019年∼2024年)
  • 北美
  • 歐洲
  • 亞洲
  • 其他地區
  • 主要國家
  • 市場機會

第9章 決策架構

第10章 成長要素與課題

  • 市場成長要素
  • 市場課題

第11章 市場趨勢

  • 新產品的償付範圍的擴大
  • 研究中新應用程式的開發增加
  • M&A的產業的整合

第12章 業者情勢

  • 概要
  • 創造性破壞狀況
  • 競爭方案

第13章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • Celularity Inc.
  • Human Regenerative Technologies LLC
  • Integra LifeSciences Holdings Corp.
  • Katena Products Inc.
  • MiMedx Group Inc.
  • NuVision Biotherapies Ltd.
  • Orthofix Medical Inc.
  • Stryker Corp.
  • Surgenex LLC
  • TissueTech Inc.

第14章 附錄

  • 調查方法
  • 簡稱的清單
  • 供應商的市場定位定義

第15章 關於TECHNAVIO

目錄
Product Code: IRTNTR40730

About this market

Technavio's amniotic membrane market analysis considers sales from cryopreserved amniotic membrane and dehydrated amniotic membrane types. Our study also finds the sales of amniotic membrane in Asia, Europe, North America, and ROW. In 2019, the cryopreserved amniotic membrane segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as increased coverage of cryopreserved products in reimbursement schemes of governments will play a significant role in the cryopreserved amniotic membrane segment to maintain its market position. Also, our global amniotic membrane market report looks at factors such as extensive use of amniotic membrane transplantation in ophthalmic surgeries, high demand for amniotic membrane in wound repair and reconstruction, and rising demand for biocompatible scaffolds. However, a limited supply of amniotic membranes, the presence of stringent regulations, and issues related to preservations and contamination may hamper the growth of the amniotic membrane industry over the forecast period.

Overview

Rising demand for biocompatible scaffolds

Amniotic membranes have become essential components in tissue engineering-based research and treatment procedures that incorporate the use of these biocompatible membranes as a scaffold. The increasing demand for naturally derived materials in tissue scaffolding has helped surge the demand for amniotic membranes. These membranes have a specialized structure and show substantial biological viability (low immunogenicity, anti-inflammatory, anti-fibrosis, and reasonable mechanical property) that makes them an ideal candidate for creating bio-scaffolds. The increasing demand for bio-scaffolds in repair and regenerative therapies for the treatment of bone, cartilage, ligament, skin, vascular tissues, neural tissues, and skeletal muscles will lead to the expansion of the global amniotic membrane market at a CAGR of over 13% during the forecast period.

Rise in the development of new applications through research

Intense growth in government funding and research activities in the global amniotic membrane market has resulted in the development of potential applications for amniotic membranes that are expected to find significant adoption in the coming years. For instance, amniotic membrane-based therapies have become an integral part of regenerative medicines. Moreover, advances in tissue preservations have resulted in the pipeline development of amniotic membranes with new preservation technologies such as viable lyopreserved human amniotic membrane (VLAM) that claims improved benefits in diabetic wound treatments and longer shelf life. Other potential developments under research include the use of amniotic membranes in tissue remodeling (denuded amniotic membrane), anti-cancer therapy, and lower nasal reconstruction. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global amniotic membrane market during the forecast period 2020-2024, view our report.

Competitive Landscape

With the presence of several major players, the global amniotic membrane market is fragmented. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading amniotic membrane manufacturers, that include Celularity Inc., Human Regenerative Technologies LLC, Integra LifeSciences Holdings Corp., Katena Products Inc., MiMedx Group Inc., NuVision Biotherapies Ltd., Orthofix Medical Inc., Stryker Corp., Surgenex LLC, and TissueTech Inc.

Also, the amniotic membrane market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
  • Market Outlook

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY TYPE

  • Market segmentation by type
  • Comparison by type
  • Cryopreserved amniotic membrane - Market size and forecast 2019-2024
  • Dehydrated amniotic membrane - Market size and forecast 2019-2024
  • Market opportunity by type

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity

PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Growing reimbursement coverage for new products
  • Rise in development of new applications through research
  • Industry consolidation through mergers and acquisitions

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption
  • Competitive scenario

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Celularity Inc.
  • Human Regenerative Technologies LLC
  • Integra LifeSciences Holdings Corp.
  • Katena Products Inc.
  • MiMedx Group Inc.
  • NuVision Biotherapies Ltd.
  • Orthofix Medical Inc.
  • Stryker Corp.
  • Surgenex LLC
  • TissueTech Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

LIST OF EXHIBITS:

  • Exhibit 01: Global pharmaceuticals market
  • Exhibit 02: Segments of global pharmaceuticals market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Vendor offerings
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2019
  • Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
  • Exhibit 10: Five forces analysis 2019
  • Exhibit 11: Five forces analysis 2024
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2019
  • Exhibit 18: Type - Market share 2019-2024 (%)
  • Exhibit 19: Comparison by type
  • Exhibit 20: Cryopreserved amniotic membrane - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 21: Cryopreserved amniotic membrane - Year-over-year growth 2020-2024 (%)
  • Exhibit 22: Dehydrated amniotic membrane - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 23: Dehydrated amniotic membrane - Year-over-year growth 2020-2024 (%)
  • Exhibit 24: Market opportunity by type
  • Exhibit 25: Customer landscape
  • Exhibit 26: Market share by geography 2019-2024 (%)
  • Exhibit 27: Geographic comparison
  • Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
  • Exhibit 30: Europe - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 31: Europe - Year-over-year growth 2020-2024 (%)
  • Exhibit 32: Asia - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 33: Asia - Year-over-year growth 2020-2024 (%)
  • Exhibit 34: ROW - Market size and forecast 2019-2024 ($ millions)
  • Exhibit 35: ROW - Year-over-year growth 2020-2024 (%)
  • Exhibit 36: Key leading countries
  • Exhibit 37: Market opportunity
  • Exhibit 38: Impact of drivers and challenges
  • Exhibit 39: Vendor landscape
  • Exhibit 40: Landscape disruption
  • Exhibit 41: Vendors covered
  • Exhibit 42: Vendor classification
  • Exhibit 43: Market positioning of vendors
  • Exhibit 44: Celularity Inc. - Vendor overview
  • Exhibit 45: Celularity Inc. - Business segments
  • Exhibit 46: Celularity Inc. - Organizational developments
  • Exhibit 47: Celularity Inc. - Key customers
  • Exhibit 48: Human Regenerative Technologies LLC - Vendor overview
  • Exhibit 49: Human Regenerative Technologies LLC - Product segments
  • Exhibit 50: Human Regenerative Technologies LLC - Key offerings
  • Exhibit 51: Integra LifeSciences Holdings Corp. - Vendor overview
  • Exhibit 52: Integra LifeSciences Holdings Corp. - Business segments
  • Exhibit 53: Integra LifeSciences Holdings Corp. - Organizational developments
  • Exhibit 54: Integra LifeSciences Holdings Corp. - Geographic focus
  • Exhibit 55: Integra LifeSciences Holdings Corp. - Segment focus
  • Exhibit 56: Integra LifeSciences Holdings Corp. - Key offerings
  • Exhibit 57: Katena Products Inc. - Vendor overview
  • Exhibit 58: Katena Products Inc. - Product segments
  • Exhibit 59: Katena Products Inc. - Organizational developments
  • Exhibit 60: Katena Products Inc. - Key offerings
  • Exhibit 61: MiMedx Group Inc. - Vendor overview
  • Exhibit 62: MiMedx Group Inc. - Business segments
  • Exhibit 63: MiMedx Group Inc. - Organizational developments
  • Exhibit 64: MiMedx Group Inc. - Key offerings
  • Exhibit 65: NuVision Biotherapies Ltd. - Vendor overview
  • Exhibit 66: NuVision Biotherapies Ltd. - Business segments
  • Exhibit 67: NuVision Biotherapies Ltd. - Organizational developments
  • Exhibit 68: NuVision Biotherapies Ltd. - Key offerings
  • Exhibit 69: Orthofix Medical Inc. - Vendor overview
  • Exhibit 70: Orthofix Medical Inc. - Business segments
  • Exhibit 71: Orthofix Medical Inc. - Organizational developments
  • Exhibit 72: Orthofix Medical Inc. - Geographic focus
  • Exhibit 73: Orthofix Medical Inc. - Segment focus
  • Exhibit 74: Orthofix Medical Inc. - Key offerings
  • Exhibit 75: Stryker Corp. - Vendor overview
  • Exhibit 76: Stryker Corp. - Business segments
  • Exhibit 77: Stryker Corp. - Organizational developments
  • Exhibit 78: Stryker Corp. - Geographic focus
  • Exhibit 79: Stryker Corp. - Segment focus
  • Exhibit 80: Stryker Corp. - Key offerings
  • Exhibit 81: Surgenex LLC - Vendor overview
  • Exhibit 82: Surgenex LLC - Product segments
  • Exhibit 83: Surgenex LLC - Key offerings
  • Exhibit 84: TissueTech Inc. - Vendor overview
  • Exhibit 85: TissueTech Inc. - Business segments
  • Exhibit 86: TissueTech Inc. - Organizational developments
  • Exhibit 87: TissueTech Inc. - Key offerings
  • Exhibit 88: Validation techniques employed for market sizing
  • Exhibit 89: Definition of market positioning of vendors
Back to Top